Medicine & Life Sciences

1. Neoplasms 100%
2. Barrett Esophagus 78%
3. Loss of Heterozygosity 75%
4. Comparative Genomic Hybridization 67%
5. Adenocarcinoma 61%
6. Genome 56%
7. Pancreatic Neoplasms 55%
8. Aneuploidy 53%
9. Oligonucleotide Array Sequence Analysis 41%
10. Triple Negative Breast Neoplasms 40%
11. Mutation 40%
12. Cholangiocarcinoma 33%
13. gemcitabine 31%
14. Population 31%
15. DNA 31%
16. Clonal Evolution 29%
17. Genes 28%
18. Chromothripsis 27%
19. Cisplatin 25%
20. Genomic Instability 24%
21. Receptor, Fibroblast Growth Factor, Type 2 23%
22. Biliary Tract Neoplasms 23%
23. Prostatic Neoplasms 22%
24. Tetraploidy 22%
25. Adenosquamous Carcinoma 22%
26. Breast Neoplasms 21%
27. Ploidies 21%
28. Diploidy 21%
29. Waldenstrom Macroglobulinemia 21%
30. Therapeutics 20%
31. NUC-1031 19%
32. Small Cell Carcinoma 19%
33. Epithelium 18%
34. Biopsy 18%
35. Pancreas 17%
36. Cytogenetics 17%
37. Heterografts 17%
38. Chromosomes 17%
39. Immunohistochemistry 16%
40. Formaldehyde 16%
41. Multiple Myeloma 15%
42. Clone Cells 15%
43. Phenotype 15%
44. Chromosome Aberrations 15%
45. Fluorescence In Situ Hybridization 15%
46. Methylation 15%
47. Cell Line 14%
48. Ovary 13%
49. Lymphoma 13%
50. Survival 13%